Yes, it does take time. It can take a long time here as well. You have products that are sitting inside the pCPA currently that are essentially stonewalled, not moving forward and not moving backwards. You're asking managers to essentially try to drive a hard bargain or get a good deal out of a manufacturer. If they don't have a product that is very high value and they're not prepared to adjust their price, then, yes, that can hold things up.
However, by the same token, as I mentioned in my opening address, when managers are given a fairly clear set of instructions—i.e., get the most health benefit you can from the budget available—it provides them with incentives to work in both directions, so things that don't look like they're a good value tend to languish until prices adjust. Things that look like very good value go through very quickly. In my experience in the past, New Zealand was, in some instances, among the first countries to fund new technologies because it considered them to be very good value.